Skip to main content
ConductScienceScienceDex

Michael Schotsaert

NIH Rank #4729
Unclaimed recordClaim profile
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 15298241Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Internal Medicine
  • Microbiology & Immunology

NIH Funding · FY2024

Linked Award Amount
$2.1M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#4,729
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Michael Schotsaert. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Michael Schotsaert as a PI. Multi-PI records show the full award amount for context.

  • 5R44AI176894-02R44
    7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
    7 Hills Pharma, LLC
    $953.5K
    award amount
  • 5R01AI160706-03R01
    Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
    University of Michigan
    $725.8K
    award amount
  • 1R21AI180874-01R21
    Impact of mucosal adjuvanted vaccines on virus transmission in preclinical animal models for SARS-CoV-2 and influenza virus infection
    Icahn School of Medicine at Mount Sinai
    $264.3K
    award amount
  • 5R21AI176069-02R21
    Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
    Icahn School of Medicine at Mount Sinai
    $204.8K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Michael Schotsaert as a PI.

7 Hills Pharma, LLC
TX
$953.5K
1 grant
University of Michigan
MI
$725.8K
1 grant
Icahn School of Medicine at Mount Sinai
NY
$469K
2 grants

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    7 Hills Pharma, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4729
  6. 2024
    Entered Top 25% Nationally
    Ranked #4729
  7. 2024
    R01 Grant Holder
  8. 2025
    Multi-Institutional Research
    Awards at 3 institutions

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Michael Schotsaert.

Pamela Tinmoi Wong
Icahn School of Medicine at Mount Sinai
3
shared awards
Pamela Tinmoi Wong
University of Michigan
2
shared awards
Siddhartha De
7 Hills Pharma, LLC
1
shared award
Upendra Marathi
7 Hills Pharma, LLC
1
shared award
William Schary
7 Hills Pharma, LLC
1
shared award

Explore further

Find collaborators for Michael Schotsaert

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →